- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05303142
Comparing Exertional Heat Illness Risk Factors Between Patients and Controls
May 19, 2023 updated by: Jo Corbett, University of Portsmouth
Comparison of Novel Putative Risk Factors for Exertional Heat Illness Between a Military Patient Cohort and Matched Control Cohort During Exercise Heat Stress
The arduous nature of military training and operations require personnel to encounter high heat load, e.g., during intense physical exertion, particularly in the heat.
These conditions reduce operational effectiveness and expose personnel to a risk of incapacitation and death from exertional heat illness (EHI).
The primary aim of this study is to compare putative 'chronic' EHI risk factors between a cohort who have suffered a history of EHI and a control cohort with no EHI history.
The secondary aim is to examine the influence of these EHI risk factors on thermoregulation during a standard heat tolerance assessment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Military training and operations present a risk of incapacitation and death from Exertional Heat Illness (EHI).
However, widely accepted EHI risk factors are absent in almost half of all United Kingdom (UK) military EHI cases, indicating that a significant number of EHI cases in military personnel involve alternative risk factors.
Risk factors for EHI can been classified along a spectrum ranging from acute (e.g.
recent poor sleep) to chronic (e.g.
low fitness), with the role of chronic risk factors supported by the observation that individuals who have suffered an EHI are at a substantially increased risk of subsequent EHI.
The primary aim of this study is to compare putative 'chronic' EHI risk factors (e.g.
composition of gastrointestinal (GI) microbiome, infection and inflammation, trait-like psychological factors) between a cohort who have suffered a history of EHI and a control cohort with no EHI history.
The secondary aim is to examine the influence of these EHI risk factors on thermoregulation during a standard heat tolerance assessment.
Study Type
Observational
Enrollment (Actual)
95
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hampshire
-
Portsmouth, Hampshire, United Kingdom, PO1 2UP
- University of Portsmouth
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Individuals who have experienced a recent exertional heat illness and matched controls with no previous history of exertional heat illness
Description
Inclusion Criteria:
Individuals with a history of EHI:
- Previous EHI episode
- Normal resting ECG
- Male or female
- 18 - 40 years
Control participants:
- No previous history of EHI
- Normal resting ECG
- Male or female
- 18 - 40 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Individuals with a history of EHI
Service personnel who have a history of EHI.
|
60-90 minutes exercise in hot (34 °C; 45% R.H.) conditions at 60%VO2max
|
|
Control participants without a history of EHI
Matched control participants with no history of EHI. They will be matched to the experimental group for parameters that are known to influence thermoregulatory responses to exercise heat-stress.
|
60-90 minutes exercise in hot (34 °C; 45% R.H.) conditions at 60%VO2max
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Core temperature
Time Frame: At 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
|
Measured using a rectal thermistor.
|
At 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
|
|
Core temperature
Time Frame: Rate of rise from 30 to 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
|
Measured using a rectal thermistor.
|
Rate of rise from 30 to 60 minutes (or test termination if earlier) of Heat Tolerance Assessment
|
|
Diversity of gastrointestinal microbiota
Time Frame: Baseline
|
Measured in stool sample.
Assessed by alpha diversity score.
|
Baseline
|
|
Diversity of gastrointestinal microbiota
Time Frame: Baseline
|
Measured in stool sample.
Assessed by beta diversity score.
|
Baseline
|
|
Abundance of gastrointestinal microbiota
Time Frame: Baseline
|
Measured in stool sample.
Assessed at level of phylum.
|
Baseline
|
|
Detection of sexually transmitted pathogens
Time Frame: Baseline
|
Assessed from urine sample.
Measured using cobas CT/NG assays.
|
Baseline
|
|
Detection of respiratory pathogens
Time Frame: Baseline
|
Assessed from throat swab.
Measured using Allplex assays.
|
Baseline
|
|
Detection of gastrointestinal pathogens
Time Frame: Baseline
|
Assessed from stool swab.
Measured using Allplex.
|
Baseline
|
|
Circulating Interleukin 6
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating Interleukin 6
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
|
Measured using ELISA
|
Post Heat Tolerance Assessment (within 15 minutes of test end)
|
|
Circulating C-Reactive Protein
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating C-Reactive Protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
|
Measured using ELISA
|
Post Heat Tolerance Assessment (within 15 minutes of test end)
|
|
Circulating Claudin 3
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating Claudin 3
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
|
Measured using ELISA
|
Post Heat Tolerance Assessment (within 15 minutes of test end)
|
|
Circulating Zonulin
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating lipopolysaccharide binding protein
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating lipopolysaccharide binding protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
|
Measured using ELISA
|
Post Heat Tolerance Assessment (within 15 minutes of test end)
|
|
Circulating intestinal fatty acid binding protein
Time Frame: Baseline
|
Measured using ELISA
|
Baseline
|
|
Circulating intestinal fatty acid binding protein
Time Frame: Post Heat Tolerance Assessment (within 15 minutes of test end)
|
Measured using ELISA
|
Post Heat Tolerance Assessment (within 15 minutes of test end)
|
|
Gastrointestinal illness symptomology questionnaire
Time Frame: Baseline
|
Visual analogue scale (0-10).
Higher scores indicate worse symptomology
|
Baseline
|
|
Gastrointestinal illness symptomology questionnaire
Time Frame: Pre Heat Tolerance Assessment
|
Visual analogue scale (0-10).
Higher scores indicate worse symptomology
|
Pre Heat Tolerance Assessment
|
|
Gastrointestinal illness symptomology questionnaire
Time Frame: Immediately post Heat Tolerance Assessment
|
Visual analogue scale (0-10).
Higher scores indicate worse symptomology
|
Immediately post Heat Tolerance Assessment
|
|
Respiratory illness symptomology, measured by Jackson common cold questionnaire
Time Frame: Baseline
|
Higher scores indicate worse symptomology
|
Baseline
|
|
Sleep quality and quantity, measured by Pittsburgh Sleep Quality Index
Time Frame: Baseline -3 days
|
Higher scores indicate worse sleep
|
Baseline -3 days
|
|
Motivation, measured by Motivation scale
Time Frame: Baseline -3 days
|
Baseline -3 days
|
|
|
State-trait anxiety, measured by state-trait anxiety inventory form Y-2
Time Frame: Baseline -3 days
|
Baseline -3 days
|
|
|
Risk taking, measured by the risk-taking inventory
Time Frame: Baseline -3 days
|
Baseline -3 days
|
|
|
Resilience, measured by the Connor-Davidson resilience scale
Time Frame: Baseline -3 days
|
Baseline -3 days
|
|
|
Stress, measured by perceived stress scale
Time Frame: Baseline -3 days
|
Baseline -3 days
|
|
|
Mental readiness
Time Frame: Baseline
|
Visual analogue scale (0-100).
Higher scores indicate a lower state of mental readiness.
|
Baseline
|
|
Stress
Time Frame: Baseline
|
Visual analogue scale (0-100).
Higher scores indicate a greater state of stress.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heat rate
Time Frame: At 5 minute intervals during the Heat Tolerance Assessment
|
At 5 minute intervals during the Heat Tolerance Assessment
|
|
|
Thermal comfort
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
|
Modified 9 point Gagge scale.
Higher scores indicate worse comfort.
|
At 15 minute intervals during Heat Tolerance Assessment
|
|
Thermal sensation
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
|
Modified 9 point Gagge scale.
Higher scores indicate hotter sensation
|
At 15 minute intervals during Heat Tolerance Assessment
|
|
Rating of Perceived Exertion
Time Frame: At 15 minute intervals during Heat Tolerance Assessment
|
6-20 Borg scale.
Higher scores indicate higher perceived exertion
|
At 15 minute intervals during Heat Tolerance Assessment
|
|
Skin Temperature
Time Frame: During Heat Tolerance Assessment
|
Weighted mean skin temperature
|
During Heat Tolerance Assessment
|
|
Sweat rate
Time Frame: During Heat Tolerance Assessment
|
Determined from change in nude body mass during the heat tolerance assessment
|
During Heat Tolerance Assessment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass
Time Frame: Baseline
|
Baseline
|
|
|
Relative maximal aerobic fitness
Time Frame: Baseline
|
Highest value measured in ml.kg-1.min-1
during a treadmill graded exercise test.
|
Baseline
|
|
Urine osmolality
Time Frame: Baseline
|
Measured using freezing point depression
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Actual)
March 6, 2023
Study Completion (Actual)
March 6, 2023
Study Registration Dates
First Submitted
February 3, 2022
First Submitted That Met QC Criteria
March 21, 2022
First Posted (Actual)
March 31, 2022
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
May 19, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 209321
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exertional Heat Illness
-
Liverpool John Moores UniversityInstitute of Naval Medicine (UK); CTCRM Lympstone (UK); University of Portsmouth... and other collaboratorsActive, not recruiting
-
University of MinnesotaCompletedHydration Status | Exertional Heat Illness
-
Erasmus Medical CenterActive, not recruitingHeat Illness | Heat Exhaustion | Heat Stroke ExertionalNetherlands
-
University of Northern IowaRecruitingAcute Kidney Injury | Exertional Heat IllnessUnited States
-
United States Army Research Institute of Environmental...CompletedHeat Stress, ExertionalUnited States
-
Medical Corps, Israel Defense ForceThe Chaim Sheba Medical CenterCompletedExertional Heat InjuryIsrael
-
United States Army Research Institute of Environmental...CompletedHeat Acclimation and Thermotolerance | Heat Stress, ExertionalUnited States
-
University of OttawaCompletedInitial Stay Times and Heat Mitigation Controls for Uncompensable Occupational Heat Stress - Part IIExercise | Core Temperature | Heat Stress, Exertional | Heat FatigueCanada
-
University of OttawaCompletedExercise | Core Temperature | Heat Stress, Exertional | Heat FatigueCanada
-
University of the PunjabLund UniversityCompletedSports Injury | Physiological Stress | Heat Stress | Heat Stress, ExertionalPakistan
Clinical Trials on Heat Tolerance Assessment
-
Sheba Medical CenterCompletedHealthy | Heat StrokeIsrael
-
Direction Centrale du Service de Santé des ArméesRecruiting
-
Umeå UniversityBaxter Healthcare CorporationCompleted
-
Roswell Park Cancer InstituteWithdrawnHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Centre Hospitalier Universitaire DijonRecruitingCommon Non-specific Low Back PainFrance
-
Université de MontréalInstitut de Recherche Robert-Sauvé en Santé et en Sécurité du TravailUnknown
-
Stanford UniversityCompletedSleep Apnea, ObstructiveUnited States
-
AdventHealth Translational Research InstituteCompletedObesityUnited States
-
Imperial College LondonNot yet recruitingVaricose Veins of Lower Limb | Chronic Venous InsufficiencyUnited Kingdom
-
Universidad Peruana Cayetano HerediaTulane University School of MedicineAvailableCutaneous Leishmaniasis